Abstract

Aliskiren (Tekturna), a direct renin inhibitor, was FDA-approved in 2007 for treatment of hypertension. Researchers conducted this industry-sponsored

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call